Mary is a cancer nurse with a clinical academic background in health services research within oncology. Her research is mainly focussed on the supportive care of people with cancer and in particular the needs, experiences and outcomes of people who have completed treatment. Mary works closely with a number of cancer charities with a major interest in improving experiences, outcomes and cancer care practice. She was a member of the Executive Board of the European Oncology Nursing Society (EONS) www.cancernurse.eu from 2009 - 2015(and Secretary from 2011-2015) and she is currentlyco-chair of theEONS Research Working Group.Since 2009 she has been a Specialist Advisor to the leading cancer charity Macmillan Cancer Support and the Consequences of Cancer Treatment Collaborative http://www.macmillan.org.uk/aboutus/whatwedo/ouresearchandevaluation/ourresearchpartners/ccat.aspx and she is on the Clinical Advisory Board of the Throat Cancer Foundation www.throatcancerfoundation.orgIn 2016 Mary was appointed as a Trustee of HealthTalk (previously DiPeX) www.healthtalk.org She has been a member of the NCRI Psychosocial Oncology and Survivorship Clinical Studies Group (CSG) since 2013 http://csg.ncri.org.uk/groups/clinical-studies-groups/psychosocial-oncology and has led the Interventions sub-group since 2015. She is also a member of the survivorship sub-group of the Head & Neck CSG.
Mary is particularly interested in health and wellbeing in cancer survivors and in developing ways of managing the psychosocial and physical consequences of cancer and its treatment. Much of her current work focusses on survivors of head and neck cancer.
Mary’s methodological expertise includes qualitative and quantitative research methods, and she has experience in a range of qualitative approaches including case study and qualitative meta-synthesis, as well as surveys and randomised controlled trials. Her PhD investigated the role of context in randomized trials of complex interventions, and she is particularly interested in the development and evaluation of complex interventions led by NMAHPs.